CN Stock MarketDetailed Quotes

600267 Zhejiang Hisun Pharmaceutical

Watchlist

8.40
+0.12+1.45%

Market Closed Dec 27 15:00 CST

10.15BMarket Cap-494.12P/E (TTM)

Zhejiang Hisun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Hisun Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	2.63B	--
		-0.37%
EPS	0.11	0.07	-0.04
Miss Est.	+83.33%	+16.67%	-36.36%

Analyst Rating

No Data

Zhejiang Hisun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 9.920B	--
--	2024/FY	-- / 9.487B	--
--	2023/FY	10.373B / 12.647B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 9.920B--

--2024/FY-- / 9.487B--

--2023/FY10.373B / 12.647B--

--------

Unlock Free Earnings Estimates

Open Account

Zhejiang Hisun Pharmaceutical Earnings Reports

Haizheng Pharmaceutical: Zhejiang Haizheng Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

Oct 30 12:00 ET

Zhejiang Haizheng Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

Oct 30 12:00 ET

Zhejiang Hisun Pharmaceutical Co., Ltd. 2024 Interim Report

Aug 19 12:00 ET

Summary of Zhejiang Hisun Pharmaceutical Co., Ltd.'s 2024 interim report.

Aug 19 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Suzhou Industrial Park Heshun Electric

300141

11.14 +20.04%

Guangdong Xiongsu Technology Group

300599

7.67 +20.03%

Sichuan Chuanhuan Technology

300547

24.41 +20.01%

Shanghai Wisdom Information Technology

See the daily top gainer.

Investment Theme

Artemisinin

Intraday+0.82%

Monoclonal Antibody Concept

Intraday+0.70%

Biomedical

Intraday+0.66%